<DOC>
	<DOCNO>NCT02802735</DOCNO>
	<brief_summary>This two-part study design evaluate Pharmacokinetics ( PK ) single multiple dos apremilast healthy adult male Korean subject .</brief_summary>
	<brief_title>Study Evaluate Pharmacokinetics Single Multiple Doses Apremilast Healthy Adult Male Korean Subjects</brief_title>
	<detailed_description>A clinical study ass pharmacokinetics apremilast healthy adult male Korean subject live Korea . The study consist two part . Part 1 evaluate PK ascend single dos apremilast . Part 2 evaluate PK apremilast administer multiple dos .</detailed_description>
	<mesh_term>Apremilast</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>Subjects must satisfy follow criterion enrol study : : 1 . Healthy adult male Korean subject 18 45 year age ( inclusive ) time sign informed consent form ( ICF ) . 2 . Subject must understand voluntarily sign ICF prior studyrelated assessments/procedures conduct . 3 . Subject willing able adhere study visit schedule protocol requirement . 4 . Must able communicate Investigator understand comply requirement study . 5 . Must good health determine Investigator accord past medical history , physical examination ( PE ) , vital sign , 12lead Electrocardiogram ( ECG ) , laboratory test . 6 . Must body mass index Body mass index ( BMI ) 18 30 kg/m2 ( inclusive ) . 7 . Clinical laboratory test must within normal limit consider Investigator clinically significant . 8 . Vital sign ( systolic diastolic blood pressure , pulse rate , oral [ tympanic ] body temperature ) assess supine position subject rest least five minute . Subject must afebrile ( febrile [ oral tympanic ] define ≥ 38°C 100.3°F ) vital sign within follow range : Systolic blood pressure : 90 140 mm Hg ; Diastolic blood pressure : 50 90 mm Hg ; Pulse rate : 40 110 bpm . 9 . Must normal clinically acceptable 12lead Electrocardiogram ( ECG ) . Subjects must QTc value ≤ 450 msec . 10 . Must normal clinically acceptable Physical examination ( PE ) . 11 . Contraception Requirements : Male subject ( include vasectomy ) engage activity conception possible must use barrier contraception ( latex nonlatex condom NOT make natural [ animal ] membrane [ example , polyurethane ] ) Investigational Product ( IP ) least 28 day last dose IP . 12 . Must agree refrain donate sperm , blood plasma ( study ) participate study , least 28 day last dose IP . The presence follow exclude healthy subject enrollment study : 1 . History clinically significant relevant neurological , psychiatric , gastrointestinal , renal , hepatic , cardiovascular , psychological , pulmonary , metabolic , endocrine , hematological , allergic disease , drug allergy , major disorder . 2 . Any condition place subject unacceptable risk participate study , confound ability interpret data study . 3 . Use prescribed systemic topical medication within 30 day first dose administration . 4 . Use nonprescribed systemic topical medication ( include vitamin/mineral supplement , herbal medicine ) within 14 day first dose administration . 5 . Any surgical medical condition possibly affect drug absorption , distribution , metabolism excretion , eg , bariatric procedure , colon resection , irritable bowel syndrome , Crohn 's disease , etc . Subjects cholecystectomy appendectomy may include . 6 . Exposure investigational drug ( new chemical entity ) within 30 day prior first dose administration 5 halflives investigational drug , know ( whichever longer ) . 7 . Donated blood plasma within eight week first dose administration blood bank blood donation center . 8 . History drug abuse ( define current version Diagnostic Statistical Manual [ DSM ] ) within 2 year dose , positive drug screen reflect consumption illicit drug . 9 . History alcohol abuse ( define current version DSM ) within 2 year dose , positive alcohol screen . 10 . Known hepatitis , know carrier HBsAg , HCV Ab , positive result test HBsAg , HCV Ab , Human Immunodeficiency Virus ( HIV ) antibodies Screening .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Apremilast</keyword>
	<keyword>Healthy Adult Male</keyword>
	<keyword>Korean Subjects</keyword>
</DOC>